NYSE:BHVN

Biohaven Pharmaceutical Holding Company Stock Forecast

etoro logo Buy BHVN
*Your capital is at risk
$15.44
+1.27 (+8.96%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of BHVN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BHVN to Watchlist?
Some Reasons Why To Add BHVN:
  • Consistently positive technical signals over the last month
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • +42.4% YTD performance
PDF

Volatile ride for Biohaven Pharmaceutical Holding Co Ltd stock price on Friday moving between $13.62 and $15.51
(Updated on Jul 17, 2026)

Buy or Hold candidate since May 27, 2026 Gain 36.76%

The Biohaven Pharmaceutical Holding Co Ltd stock price gained 8.96% on the last trading day (Friday, 17th Jul 2026), rising from $14.17 to $15.44. During the last trading day the stock fluctuated 13.88% from a day low at $13.62 to a day high of $15.51. The price has fallen in 6 of the last 10 days and is down by -3.26% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $48.98 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 76.57% during the next 3 months and, with a 90% probability hold a price between $23.62 and $30.97 at the end of this 3-month period.

BHVN Signals & Forecast

The Biohaven Pharmaceutical Holding Co Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.27 and $13.61. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -8.04%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Biohaven Pharmaceutical Holding Co Ltd stock

Biohaven Pharmaceutical Holding Co Ltd finds support from accumulated volume at $15.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.89 between high and low, or 13.88%. For the last week, the stock has had daily average volatility of 6.16%.

Our recommended stop-loss: $14.50 (-6.06%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (BHVN) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Biohaven Pharmaceutical Holding Company Ltd to open at $14.86, and during the day (based on 14 day Average True Range), to move between $14.91 and $15.97, which gives a possible trading interval of +/-$1.06 (+/-7.08%) up or down from last closing price. If Biohaven Pharmaceutical Holding Company Ltd takes out the full calculated possible swing range there will be an estimated 7.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.50 (0.39%) than the support at $15.34 (0.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Biohaven Pharmaceutical Holding Company Ltd stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Biohaven Pharmaceutical Holding Co Ltd stock to perform well in the short-term.

Current score: 3.843 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $14.86 ( 3.78%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BHVN Performance

Trading levels for BHVN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.75 8.46%
R2 16.02 3.79%
R1 15.58 0.90%
Price 15.44
S1 14.13 -8.45%
S2 13.69 -11.34%
S3 12.97 -16.02%

Accumulated Volume Support & Resistance Levels

Level Price
R3 15.76 2.07%
R2 15.55 0.712%
R1 15.50 0.389%
Price 15.44
S1 15.34 -0.648%
S2 13.62 -11.79%
S3 13.57 -12.11%

FAQ

What is the symbol for Biohaven Pharmaceutical Holding Company Ltd Stock and on which exchange is it traded?
The symbol for Biohaven Pharmaceutical Holding Company Ltd is BHVN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Biohaven Pharmaceutical Holding Company Ltd Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Biohaven Pharmaceutical Holding Co Ltd stock to perform well in the short-term.

How to buy Biohaven Pharmaceutical Holding Company Ltd Stock?
Biohaven Pharmaceutical Holding Company Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biohaven Pharmaceutical Holding Company Ltd Stock.

What's the current price of Biohaven Pharmaceutical Holding Company Ltd Stock?
As of the end of day on the Jul 17, 2026, the price of an Biohaven Pharmaceutical Holding Company Ltd (BHVN) share was $15.44.

What is the 52-week high and low for Biohaven Pharmaceutical Holding Company Ltd Stock?
The 52-week high for Biohaven Pharmaceutical Holding Company Ltd Stock is $18.57 and the 52-week low is $7.48.

What is the market capitalization of Biohaven Pharmaceutical Holding Company Ltd Stock?
As of the Jul 17, 2026, the market capitalization of Biohaven Pharmaceutical Holding Company Ltd is 1.635B.

When is the next earnings date for Biohaven Pharmaceutical Holding Company Ltd?
The upcoming earnings date for Biohaven Pharmaceutical Holding Company Ltd is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD
Biohaven Pharmaceutical Holding Company
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE